|
|
(12 intermediate revisions by 5 users not shown) |
Line 1: |
Line 1: |
| {{headerpanel|{{Approval}}}} | | {{headerpanel|{{Approval}}}} |
| {{SummarySheet}} | | {{SummarySheet}} |
| {{SubstanceBox | | {{SubstanceBox/HXE}} |
| | |
| <!-- Special Parameters -->
| |
| |displayClasses={{{displayClasses|}}}
| |
| |MaterialTable_MaxWidth=250px
| |
| |MaterialTable_Title={{PAGENAME}}
| |
| | |
| <!-- Modules -->
| |
| |ModuleSource=false
| |
| |ModuleCombination=false
| |
| |ModuleStructure=true
| |
| |ModuleNomenclature=true
| |
| |ModuleClassMembership=true
| |
| |ModuleROA=true
| |
| | |
| <!-- Source -->
| |
| |PhotoImageFile=
| |
| |PhotoImageWidth=
| |
| |PhotoImageCaption=
| |
| | |
| <!-- Combination -->
| |
| |CombinationImage1_Caption=
| |
| |CombinationImage1_File=
| |
| |CombinationImage1_Width=
| |
| | |
| |CombinationImage2_Caption=
| |
| |CombinationImage2_File=
| |
| |CombinationImage2_Width=
| |
| | |
| |CombinationImage3_Caption=
| |
| |CombinationImage3_File=
| |
| |CombinationImage3_Width=
| |
| | |
| <!-- Structure -->
| |
| |MolecularStructureCaption=
| |
| |SkeletalImageFile=File:HXE.svg
| |
| |SkeletalImageWidth=245px
| |
| |3DImageFile=
| |
| |3DImageWidth=
| |
| | |
| <!-- Nomenclature -->
| |
| |NameCommon=HXE
| |
| |NameSubstitution=3-HO-2'-Oxo-PCE
| |
| |NameSystematic=2-(Ethylamino)-2-(3-hydroxyphenyl)cyclohexan-1-one
| |
| | |
| <!-- Class Membership -->
| |
| |EffectClass=[[psychoactive class::Dissociative]]
| |
| |ChemicalClass=[[chemical class::Arylcyclohexylamine]]
| |
| | |
| <!-- Dosage/Duration per ROA -->
| |
| | |
| |OralROA=true
| |
| |OralROA_Collapsed=false
| |
| |OralROA_Caption=
| |
| |OralROA_Bioavailability=[[Oral min bioavailability::x]]% - [[Oral max bioavailability::y]]%<ref>APA formatted citation.</ref> <!-- Refer to this tool to generate APA citations from DOI links: https://reftag.appspot.com/doiweb.py -->
| |
| |OralROA_Microdose=
| |
| |OralROA_Threshold=[[Oral threshold dose::30]] - [[Oral dose units::mg]]
| |
| |OralROA_Light=[[Oral min light dose::30]] - [[Oral max light dose::60]] mg
| |
| |OralROA_Common=[[Oral min common dose::60]] - [[Oral max common dose::100]] mg
| |
| |OralROA_Strong=[[Oral min strong dose::100]] - [[Oral max strong dose::130]] mg
| |
| |OralROA_Heavy=[[Oral heavy dose::130]] mg +
| |
| |OralROA_TimelineFile=
| |
| |OralROA_TimelineWidth=
| |
| |OralROA_Duration=[[Oral min total time::x]] - [[Oral max total time::y]] [[Oral total time units::hours]]
| |
| |OralROA_Onset=[[Oral min onset time::x]] - [[Oral max onset time::y]] [[Oral onset time units::minutes]]
| |
| |OralROA_Comeup=[[Oral min comeup time::x]] - [[Oral max comeup time::y]] [[Oral comeup time units::minutes]]
| |
| |OralROA_Peak=[[Oral min peak time::x]] - [[Oral max peak time::y]] [[Oral peak time units::hours]]
| |
| |OralROA_Offset=[[Oral min offset time::x]] - [[Oral max offset time::y]] [[Oral offset time units::hours]]
| |
| |OralROA_Aftereffects=[[Oral min afterglow time::x]] - [[Oral max afterglow time::y]] [[Oral afterglow time units::hours]]
| |
| | |
| |SublingualROA=true
| |
| |SublingualROA_Collapsed=false
| |
| |SublingualROA_Caption=
| |
| |SublingualROA_Bioavailability=[[Sublingual min bioavailability::x]]% - [[Sublingual max bioavailability::y]]%
| |
| |SublingualROA_Microdose=
| |
| |SublingualROA_Threshold=[[Sublingual threshold dose::30]] - [[Sublingual dose units::mg]]
| |
| |SublingualROA_Light=[[Sublingual min light dose::30]] - [[Sublingual max light dose::y]] mg
| |
| |SublingualROA_Common=[[Sublingual min common dose::60]] - [[Sublingual max common dose::y]] mg
| |
| |SublingualROA_Strong=[[Sublingual min strong dose::10ü]] - [[Sublingual max strong dose::y]] mg
| |
| |SublingualROA_Heavy=[[Sublingual heavy dose::13ü]] mg +
| |
| |SublingualROA_TimelineFile=
| |
| |SublingualROA_TimelineWidth=
| |
| |SublingualROA_Duration=[[Sublingual min total time::a]] - [[Sublingual max total time::b]] [[Sublingual total time units::hours]]
| |
| |SublingualROA_Onset=[[Sublingual min onset time::a]] - [[Sublingual max onset time::b]] [[Sublingual onset time units::minutes]]
| |
| |SublingualROA_Comeup=[[Sublingual min comeup time::a]] - [[Sublingual max comeup time::b]] [[Sublingual comeup time units::minutes]]
| |
| |SublingualROA_Peak=[[Sublingual min peak time::a]] - [[Sublingual max peak time::b]] [[Sublingual peak time units::hours]]
| |
| |SublingualROA_Offset=[[Sublingual min offset time::a]] - [[Sublingual max offset time::b]] [[Sublingual offset time units::hours]]
| |
| |SublingualROA_Aftereffects=[[Sublingual min afterglow time::a]] - [[Sublingual max afterglow time::b]] [[Sublingual afterglow time units::hours]]
| |
| | |
| |BuccalROA=false
| |
| |BuccalROA_Collapsed=True
| |
| |BuccalROA_Caption=
| |
| |BuccalROA_Bioavailability=[[Buccal min bioavailability::x]]% - [[Buccal max bioavailability::y]]%<ref>APA formatted citation</ref>
| |
| |BuccalROA_Microdose=
| |
| |BuccalROA_Threshold=[[Buccal threshold dose::x]] - [[Buccal dose units::mg]]
| |
| |BuccalROA_Light=[[Buccal min light dose::x]] - [[Buccal max light dose::y]] mg
| |
| |BuccalROA_Common=[[Buccal min common dose::x]] - [[Buccal max common dose::y]] mg
| |
| |BuccalROA_Strong=[[Buccal min strong dose::x]] - [[Buccal max strong dose::y]] mg
| |
| |BuccalROA_Heavy=[[Buccal heavy dose::x]] mg +
| |
| |BuccalROA_TimelineFile=
| |
| |BuccalROA_TimelineWidth=
| |
| |BuccalROA_Duration=[[Buccal min total time::x]] - [[Buccal max total time::y]] [[Buccal total time units::hours]]
| |
| |BuccalROA_Onset=[[Buccal min onset time::x]] - [[Buccal max onset time::y]] [[Buccal onset time units::minutes]]
| |
| |BuccalROA_Comeup=[[Buccal min comeup time::x]] - [[Buccal max comeup time::y]] [[Buccal comeup time units::minutes]]
| |
| |BuccalROA_Peak=[[Buccal min peak time::x]] - [[Buccal max peak time::y]] [[Buccal peak time units::hours]]
| |
| |BuccalROA_Offset=[[Buccal min offset time::x]] - [[Buccal max offset time::y]] [[Buccal offset time units::hours]]
| |
| |BuccalROA_Aftereffects=[[Buccal min afterglow time::x]] - [[Buccal max afterglow time::y]] [[Buccal afterglow time units::hours]]
| |
| | |
| |InsufflatedROA=true
| |
| |InsufflatedROA_Collapsed=false
| |
| |InsufflatedROA_Caption=
| |
| |InsufflatedROA_Bioavailability=[[Insufflated min bioavailability::x]]% - [[Insufflated max bioavailability::y]]%<ref>APA formatted citation</ref>
| |
| |InsufflatedROA_Microdose=
| |
| |InsufflatedROA_Threshold=[[Insufflated threshold dose::20]] - [[Insufflated dose units::mg]]
| |
| |InsufflatedROA_Light=[[Insufflated min light dose::40]] - [[Insufflated max light dose::20]] mg
| |
| |InsufflatedROA_Common=[[Insufflated min common dose::40]] - [[Insufflated max common dose::70]] mg
| |
| |InsufflatedROA_Strong=[[Insufflated min strong dose::70]] - [[Insufflated max strong dose::120]] mg
| |
| |InsufflatedROA_Heavy=[[Insufflated heavy dose::120]] mg +
| |
| |InsufflatedROA_TimelineFile=
| |
| |InsufflatedROA_TimelineWidth=
| |
| |InsufflatedROA_Duration=[[Insufflated min total time::4]] - [[Insufflated max total time::8]] [[Insufflated total time units::hours]]
| |
| |InsufflatedROA_Onset=[[Insufflated min onset time::10]] - [[Insufflated max onset time::30]] [[Insufflated onset time units::minutes]]
| |
| |InsufflatedROA_Comeup=[[Insufflated min comeup time::20]] - [[Insufflated max comeup time::40]] [[Insufflated comeup time units::minutes]]
| |
| |InsufflatedROA_Peak=[[Insufflated min peak time::1.5]] - [[Insufflated max peak time::4]] [[Insufflated peak time units::hours]]
| |
| |InsufflatedROA_Offset=[[Insufflated min offset time::2]] - [[Insufflated max offset time:4]] [[Insufflated offset time units::hours]]
| |
| |InsufflatedROA_Aftereffects=[[Insufflated min afterglow time::2]] - [[Insufflated max afterglow time:7]] [[Insufflated afterglow time units::hours]]
| |
| | |
| |RectalROA=false
| |
| |RectalROA_Collapsed=True
| |
| |RectalROA_Caption=
| |
| |RectalROA_Bioavailability=[[Rectal min bioavailability::x]]% - [[Rectal max bioavailability::y]]
| |
| |RectalROA_Microdose=
| |
| |RectalROA_Threshold=[[Rectal threshold dose::x]] - [[Rectal dose units::mg]]
| |
| |RectalROA_Light=[[Rectal min light dose::x]] - [[Rectal max light dose::y]] mg
| |
| |RectalROA_Common=[[Rectal min common dose::x]] - [[Rectal max common dose::y]] mg
| |
| |RectalROA_Strong=[[Rectal min strong dose::x]] - [[Rectal max strong dose::y]] mg
| |
| |RectalROA_Heavy=[[Rectal heavy dose::x]] mg +
| |
| |RectalROA_TimelineFile=
| |
| |RectalROA_TimelineWidth=
| |
| |RectalROA_Duration=[[Rectal min total time::x]] - [[Rectal max total time::y]] [[Rectal total time units::hours]]
| |
| |RectalROA_Onset=[[Rectal min onset time::x]] - [[Rectal max onset time::y]] [[Rectal onset time units::minutes]]
| |
| |RectalROA_Comeup=[[Rectal min comeup time::x]] - [[Rectal max comeup time::y]] [[Rectal comeup time units::minutes]]
| |
| |RectalROA_Peak=[[Rectal min peak time::x]] - [[Rectal max peak time::y]] [[Rectal peak time units::hours]]
| |
| |RectalROA_Offset=[[Rectal min offset time::x]] - [[Rectal max offset time::y]] [[Rectal offset time units::hours]]
| |
| |RectalROA_Aftereffects=[[Rectal min afterglow time::x]] - [[Rectal max afterglow time::y]] [[Rectal afterglow time units::hours]]
| |
| | |
| |TransdermalROA=false
| |
| |TransdermalROA_Collapsed=True
| |
| |TransdermalROA_Caption=
| |
| |TransdermalROA_Bioavailability=[[Transdermal min bioavailability::x]]% - [[Transdermal max bioavailability::y]]%<ref>APA formatted citation</ref>
| |
| |TransdermalROA_Microdose=
| |
| |TransdermalROA_Threshold=[[Transdermal threshold dose::x]] - [[Transdermal dose units::mg]]
| |
| |TransdermalROA_Light=[[Transdermal min light dose::x]] - [[Transdermal max light dose::y]] mg
| |
| |TransdermalROA_Common=[[Transdermal min common dose::x]] - [[Transdermal max common dose::y]] mg
| |
| |TransdermalROA_Strong=[[Transdermal min strong dose::x]] - [[Transdermal max strong dose::y]] mg
| |
| |TransdermalROA_Heavy=[[Transdermal heavy dose::x]] mg +
| |
| |TransdermalROA_TimelineFile=
| |
| |TransdermalROA_TimelineWidth=
| |
| |TransdermalROA_Duration=[[Transdermal min total time::x]] - [[Transdermal max total time::y]] [[Transdermal total time units::hours]]
| |
| |TransdermalROA_Onset=[[Transdermal min onset time::x]] - [[Transdermal max onset time::y]] [[Transdermal onset time units::minutes]]
| |
| |TransdermalROA_Comeup=[[Transdermal min comeup time::x]] - [[Transdermal max comeup time::y]] [[Transdermal comeup time units::minutes]]
| |
| |TransdermalROA_Peak=[[Transdermal min peak time::x]] - [[Transdermal max peak time::y]] [[Transdermal peak time units::hours]]
| |
| |TransdermalROA_Offset=[[Transdermal min offset time::x]] - [[Transdermal max offset time::y]] [[Transdermal offset time units::hours]]
| |
| |TransdermalROA_Aftereffects=[[Transdermal min afterglow time::x]] - [[Transdermal max afterglow time::y]] [[Transdermal afterglow time units::hours]]
| |
| | |
| |SubcutaneousROA=false
| |
| |SubcutaneousROA_Collapsed=True
| |
| |SubcutaneousROA_Caption=
| |
| |SubcutaneousROA_Bioavailability=[[Subcutaneous min bioavailability::x]]% - [[Subcutaneous max bioavailability::y]]%<ref>APA formatted citation</ref>
| |
| |SubcutaneousROA_Microdose=
| |
| |SubcutaneousROA_Threshold=[[Subcutaneous threshold dose::x]] - [[Subcutaneous dose units::mg]]
| |
| |SubcutaneousROA_Light=[[Subcutaneous min light dose::x]] - [[Subcutaneous max light dose::y]] mg
| |
| |SubcutaneousROA_Common=[[Subcutaneous min common dose::x]] - [[Subcutaneous max common dose::y]] mg
| |
| |SubcutaneousROA_Strong=[[Subcutaneous min strong dose::x]] - [[Subcutaneous max strong dose::y]] mg
| |
| |SubcutaneousROA_Heavy=[[Subcutaneous heavy dose::x]] mg +
| |
| |SubcutaneousROA_TimelineFile=
| |
| |SubcutaneousROA_TimelineWidth=
| |
| |SubcutaneousROA_Duration=[[Subcutaneous min total time::x]] - [[Subcutaneous max total time::y]] [[Subcutaneous total time units::hours]]
| |
| |SubcutaneousROA_Onset=[[Subcutaneous min onset time::x]] - [[Subcutaneous max onset time::y]] [[Subcutaneous onset time units::minutes]]
| |
| |SubcutaneousROA_Comeup=[[Subcutaneous min comeup time::x]] - [[Subcutaneous max comeup time::y]] [[Subcutaneous comeup time units::minutes]]
| |
| |SubcutaneousROA_Peak=[[Subcutaneous min peak time::x]] - [[Subcutaneous max peak time::y]] [[Subcutaneous peak time units::hours]]
| |
| |SubcutaneousROA_Offset=[[Subcutaneous min offset time::x]] - [[Subcutaneous max offset time::y]] [[Subcutaneous offset time units::hours]]
| |
| |SubcutaneousROA_Aftereffects=[[Subcutaneous min afterglow time::x]] - [[Subcutaneous max afterglow time::y]] [[Subcutaneous afterglow time units::hours]]
| |
| | |
| |IntramuscularROA=false
| |
| |IntramuscularROA_Collapsed=true
| |
| |IntramuscularROA_Caption=
| |
| |IntramuscularROA_Bioavailability=[[Intramuscular min bioavailability::x]]% - [[Intramuscular max bioavailability::y]]%<ref>APA formatted citation</ref>
| |
| |IntramuscularROA_Microdose=
| |
| |IntramuscularROA_Threshold=[[Intramuscular threshold dose::x]] - [[Intramuscular dose units::mg]]
| |
| |IntramuscularROA_Light=[[Intramuscular min light dose::x]] - [[Intramuscular max light dose::y]] mg
| |
| |IntramuscularROA_Common=[[Intramuscular min common dose::x]] - [[Intramuscular max common dose::y]] mg
| |
| |IntramuscularROA_Strong=[[Intramuscular min strong dose::x]] - [[Intramuscular max strong dose::y]] mg
| |
| |IntramuscularROA_Heavy=[[Intramuscular heavy dose::x]] mg +
| |
| |IntramuscularROA_TimelineFile=
| |
| |IntramuscularROA_TimelineWidth=
| |
| |IntramuscularROA_Duration=[[Intramuscular min total time::x]] - [[Intramuscular max total time::y]] [[Intramuscular total time units::hours]]
| |
| |IntramuscularROA_Onset=[[Intramuscular min onset time::x]] - [[Intramuscular max onset time::y]] [[Intramuscular onset time units::minutes]]
| |
| |IntramuscularROA_Comeup=[[Intramuscular min comeup time::x]] - [[Intramuscular max comeup time::y]] [[Intramuscular comeup time units::minutes]]
| |
| |IntramuscularROA_Peak=[[Intramuscular min peak time::x]] - [[Intramuscular max peak time::y]] [[Intramuscular peak time units::hours]]
| |
| |IntramuscularROA_Offset=[[Intramuscular min offset time::x]] - [[Intramuscular max offset time::y]] [[Intramuscular offset time units::hours]]
| |
| |IntramuscularROA_Aftereffects=[[Intramuscular min afterglow time::x]] - [[Intramuscular max afterglow time::y]] [[Intramuscular afterglow time units::hours]]
| |
| | |
| |IntravenousROA=false
| |
| |IntravenousROA_Collapsed=true
| |
| |IntravenousROA_Caption=
| |
| |IntravenousROA_Bioavailability=[[Intravenous min bioavailability::x]]% - [[Intravenous max bioavailability::y]]%<ref>APA formatted citation</ref>
| |
| |IntravenousROA_Microdose=
| |
| |IntravenousROA_Threshold=[[Intravenous threshold dose::x]] - [[Intravenous dose units::mg]]
| |
| |IntravenousROA_Light=[[Intravenous min light dose::x]] - [[Intravenous max light dose::y]] mg
| |
| |IntravenousROA_Common=[[Intravenous min common dose::x]] - [[Intravenous max common dose::y]] mg
| |
| |IntravenousROA_Strong=[[Intravenous min strong dose::x]] - [[Intravenous max strong dose::y]] mg
| |
| |IntravenousROA_Heavy=[[Intravenous heavy dose::x]] mg +
| |
| |IntravenousROA_TimelineFile=
| |
| |IntravenousROA_TimelineWidth=
| |
| |IntravenousROA_Duration=[[Intravenous min total time::x]] - [[Intravenous max total time::y]] [[Intravenous total time units::hours]]
| |
| |IntravenousROA_Onset=[[Intravenous min onset time::x]] - [[Intravenous max onset time::y]] [[Intravenous onset time units::minutes]]
| |
| |IntravenousROA_Comeup=[[Intravenous min comeup time::x]] - [[Intravenous max comeup time::y]] [[Intravenous comeup time units::minutes]]
| |
| |IntravenousROA_Peak=[[Intravenous min peak time::x]] - [[Intravenous max peak time::y]] [[Intravenous peak time units::hours]]
| |
| |IntravenousROA_Offset=[[Intravenous min offset time::x]] - [[Intravenous max offset time::y]] [[Intravenous offset time units::hours]]
| |
| |IntravenousROA_Aftereffects=[[Intravenous min afterglow time::x]] - [[Intravenous max afterglow time::y]] [[Intravenous afterglow time units::hours]]
| |
| | |
| }} | |
| | |
|
| |
|
|
| |
|
Line 246: |
Line 23: |
| {{Preamble/SubjectiveEffects}} | | {{Preamble/SubjectiveEffects}} |
|
| |
|
| HXE's effects resemble rather the effects of [[MXPr]], [[MXE]], [[DCK]] than more chaotic derivatives like [[O-PCE]] or [[MXiPr]]. Compared to [[MXE]], it has less of a warmth to it and is weaker in its euphoria and clearheadedness, which can roughly be considered equal to [MXPr]]'s potency. | | HXE's effects resemble rather the effects of [[MXPr]], [[MXE]], [[DCK]] than more chaotic derivatives like [[O-PCE]] or [[MXiPr]]. Compared to [[MXE]], it has less of a warmth to it and is weaker in its euphoria and clearheadedness, which can roughly be considered equal to [[MXPr]]'s potency. |
|
| |
|
| {{effects/base | | {{effects/base |
Line 266: |
Line 43: |
| *'''[[Effect::Optical sliding]]''' | | *'''[[Effect::Optical sliding]]''' |
| *'''[[Effect::Orgasm suppression]]''' - Orgasm enhancement can also be present, even at higher doses. | | *'''[[Effect::Orgasm suppression]]''' - Orgasm enhancement can also be present, even at higher doses. |
|
| |
| }}
| |
| {{effects/disconnective|
| |
| *'''[[Effect::Tactile disconnection]]'''
| |
| *'''[[Effect::Visual disconnection]]''' - This eventually results in HXE's equivalent of the "k-hole" or more specifically, ''[[Visual disconnection#Holes, spaces and voids|holes, spaces and voids]]'' alongside of ''[[Visual disconnection#Structures|structures]]''.
| |
| *'''[[Effect::Consciousness disconnection]]'''
| |
|
| |
|
| }} | | }} |
|
| |
|
|
| |
| }}
| |
| {{effects/visual| | | {{effects/visual| |
| ====Suppression==== | | ====Suppression==== |
Line 299: |
Line 68: |
| *'''[[Effect::External hallucination]]''' (''[[effect::autonomous entities]]''; ''[[effect::settings, sceneries, and landscapes]]''; ''[[effect::perspective hallucinations]]'' and ''[[effect::scenarios and plots]]'') - In comparison to other [[dissociative]]s, this effect can occur at heavy doses, but is extremely infrequent in comparison to the same effect found within [[deliriant]]s. It can be comprehensively described through its [[Visual_effects:_Internal_hallucinations#Variations|variations]] as delirious in believability, autonomous in controllability and solid in style. The most common theme for this effect to follow is one of experiencing and talking to friends when they are not actually present. | | *'''[[Effect::External hallucination]]''' (''[[effect::autonomous entities]]''; ''[[effect::settings, sceneries, and landscapes]]''; ''[[effect::perspective hallucinations]]'' and ''[[effect::scenarios and plots]]'') - In comparison to other [[dissociative]]s, this effect can occur at heavy doses, but is extremely infrequent in comparison to the same effect found within [[deliriant]]s. It can be comprehensively described through its [[Visual_effects:_Internal_hallucinations#Variations|variations]] as delirious in believability, autonomous in controllability and solid in style. The most common theme for this effect to follow is one of experiencing and talking to friends when they are not actually present. |
|
| |
|
| }} | | }}| |
|
| |
|
| |{{effects/cognitive|
| | {{effects/cognitive| |
| HXE is generally considered to be euphoric and comfortable. It can also turn mildly confusing, although it's manageable and not nearly as wild as [[O-PCE]] or [[MXiPr]]. It is mostly clear-headed in comparison to that of [[DXM]] and [[ketamine]]. The specific cognitive effects can be broken down into several separate subcomponents which are listed and described below: | | HXE is generally considered to be euphoric and comfortable. It can also turn mildly confusing, although it's manageable and not nearly as wild as [[O-PCE]] or [[MXiPr]]. It is mostly clear-headed in comparison to that of [[DXM]] and [[ketamine]]. The specific cognitive effects can be broken down into several separate subcomponents which are listed and described below: |
|
| |
|
Line 335: |
Line 104: |
|
| |
|
| }} | | }} |
| | |
| | {{effects/disconnective| |
| | *'''[[Effect::Tactile disconnection]]''' |
| | *'''[[Effect::Visual disconnection]]''' - This eventually results in HXE's equivalent of the "k-hole" or more specifically, ''[[Visual disconnection#Holes, spaces and voids|holes, spaces and voids]]'' alongside of ''[[Visual disconnection#Structures|structures]]''. |
| | *'''[[Effect::Consciousness disconnection]]''' |
| | |
| | }} |
| | |
| {{effects/transpersonal| | | {{effects/transpersonal| |
| *'''[[Effect::Existential self-realization]]''' | | *'''[[Effect::Existential self-realization]]''' |
Line 346: |
Line 123: |
| <!-- | | <!-- |
| Additional experience reports can be found here: | | Additional experience reports can be found here: |
| * [https://www.erowid.org/experiences/subs/exp_SUBSTANCE.shtml Erowid Experience Vaults: SUBSTANCE] <!-- Check the link to see if it exists --> | | * [https://www.erowid.org/experiences/subs/exp_SUBSTANCE.shtml Erowid Experience Vaults: SUBSTANCE] <!-- Check the link to see if it exists -> |
| --> | | --> |
| ==Toxicity and harm potential== | | ==Toxicity and harm potential== |
Line 356: |
Line 133: |
|
| |
|
| ===Lethal dosage=== | | ===Lethal dosage=== |
| The lethal dosage of HXE is not known. Based on it's effect it could probably be assumed, that it might carry roughly the same risk of death like similar compounnds like [[DMXE]] or [[MXPr]]. | | The lethal dosage of HXE is not known. Based on it's effect it could probably be assumed, that it might carry roughly the same risk of death like similar compounds like [[DMXE]] or [[MXPr]]. |
|
| |
|
| ===Tolerance and addiction potential=== | | ===Tolerance and addiction potential=== |
Line 366: |
Line 143: |
| after that, it takes about [[time to half tolerance::3 - 7 days]] for the tolerance to be reduced to half and [[time to zero tolerance::1 - 2 weeks]] to be back at baseline (in the absence of further consumption). | | after that, it takes about [[time to half tolerance::3 - 7 days]] for the tolerance to be reduced to half and [[time to zero tolerance::1 - 2 weeks]] to be back at baseline (in the absence of further consumption). |
|
| |
|
| HXE presents cross-tolerance with [[cross-tolerance::all [[dissociative]]s]], meaning that after the consumption of mxe all [[dissociative]]s will have a reduced effect. | | HXE presents cross-tolerance with [[cross-tolerance::all [[dissociative]]s]], meaning that after the consumption of HXE all [[dissociative]]s will have a reduced effect. |
|
| |
|
| ===Dangerous interactions=== | | ===Dangerous interactions=== |
Line 381: |
Line 158: |
|
| |
|
| ==See also== | | ==See also== |
| | |
| *[[Responsible use]] | | *[[Responsible use]] |
| *[[MXE]] | | *[[MXE]] |
Line 388: |
Line 166: |
|
| |
|
| ==External links== | | ==External links== |
| {{#l:HXE.svg}}
| | |
| * https://isomerdesign.com/PiHKAL/explore.php?domain=pk&id=7505&name=HXE | | *[https://isomerdesign.com/PiHKAL/explore.php?domain=pk&id=7505&name=HXE HXE (Isomerdesign)] |
|
| |
|
| ==References== | | ==References== |
| <references /> | | <references /> |
|
| |
|
| [[Category:Psychoactive substance]][[Category:Proofread]][[Category:Approval]] | | [[Category:Psychoactive substance]] |
| | [[Category:Proofread]] |
| | [[Category:Approval]] |
|
| |
|
|
| |
|
| Please see the [[citation formatting guide]] if you need assistance properly formatting citations. | | Please see the [[citation formatting guide]] if you need assistance properly formatting citations. |
|
| |
|
| ==References==
| | [[Category:Psychoactive substance]] |
| <references />
| | [[Category:Proofread]] |
| | | [[Category:Approval]] |
| [[Category:Psychoactive substance]][[Category:Proofread]][[Category:Approval]] | |